-
23andMe Announces Intent to Voluntarily DelistĀ from Nasdaq and Deregister with the SEC
-
Regeneron (REGN) to Acquire 23andMe in Court-Supervised Sale
-
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
-
23andMe Provides Update Regarding Court-Supervised Sale Process

